ונקומיצין ויאטריס 1000מג

País: Israel

Idioma: hebreu

Font: Ministry of Health

Compra'l ara

ingredients actius:

VANCOMYCIN AS HYDROCHLORIDE

Disponible des:

GENMEDIX , ISRAEL

Codi ATC:

A07AA09

formulario farmacéutico:

LYOPHILIZED POWDER FOR INJECTION

Composición:

VANCOMYCIN AS HYDROCHLORIDE 1000 MG/VIAL

Vía de administración:

תוך-ורידי, פומי

tipo de receta:

מרשם נדרש

Fabricat per:

VIATRIS SANTE, FRANCE

Grupo terapéutico:

VANCOMYCIN

Área terapéutica:

VANCOMYCIN

indicaciones terapéuticas:

Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

Data d'autorització:

2021-10-31

Documents en altres idiomes

Informació per a l'usuari Informació per a l'usuari anglès 15-05-2017
Fitxa tècnica Fitxa tècnica anglès 07-03-2023
Informe d'Avaluació Pública Informe d'Avaluació Pública anglès 17-08-2016